| Drug Name: | deoxycholate (302-95-4) |
|---|---|
| PubChem ID: | 91810855 |
| SMILES: | C[C@H](CCC(=O)[O-])[C@H]1CCC2[C@@]1([C@H](CC3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+] |
| InchiKey: | FHHPUSMSKHSNKW-WGRCLTAPSA-M |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 414.562 |
| LogP | : | 0.1472 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 80.59 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Significant Cell Death Inhibition Of Enzymatic Activities Of B16/F10 Melanoma Cells | D-dopachrome decarboxylase (P30046) | The higher concentrations of antifungal reagent Fungizone (amphotericin B and deoxycholate) caused a significant cell death and the inhibition of enzymatic activities of B16/F10 melanoma cells through activation in dopachrome tautomerase and dopa oxidase activities. [ ADR Type 1 ] | Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|